Cherpunov A A, Kudoiarova-Zubavichene N M, Dedkova L M, Sergeev N N, Netesov S V
Vestn Ross Akad Med Nauk. 1998(4):24-9.
Methods for preventing and treating Ebola virus hemorrhagic fever are not still available despite the fact that this virus have been studied for 20 years. Methods of immunization of the animals (sheep, goats) non-susceptible to Ebola virus with live virus preparations were developed to obtain the hyperimmune anti-Ebola virus sera required to have highly immune antivirus gamma-globulins. These methods made it possible to obtain the immune sera having high virus-neutralizing antibodies. Caprine immunoglobulins were obtained from sera by fractionation of immune sera by Kohn's method. The neutralization indices of the immunoglobulins obtained were at least Ig. When administered in the first hours of infection, the protective effect of these preparations was shown on guinea pigs infected with LD50 of the strain pathogenic to the animals. Preclinical trials of these immunoglobulins on laboratory animals and clinical trials on volunteers were performed. The preparation was used as a preventive agent when accidents took place at the laboratory working with Ebola virus. The similar preparation from equine sera having high neutralizing and protective properties was elaborated at the Virological Center, Microbiological Institute, Russian Ministry of Defense. Its prophylactic efficiency was also shown in infected gamadrias.
尽管埃博拉病毒出血热已被研究了20年,但预防和治疗该疾病的方法仍然没有。为了获得具有高免疫抗病毒γ-球蛋白所需的超免疫抗埃博拉病毒血清,人们开发了用活病毒制剂免疫对埃博拉病毒不敏感的动物(绵羊、山羊)的方法。这些方法使得获得具有高病毒中和抗体的免疫血清成为可能。通过科恩方法对免疫血清进行分级分离,从血清中获得了山羊免疫球蛋白。所获得的免疫球蛋白的中和指数至少为Ig。在感染后的最初几个小时内给予这些制剂时,其对感染了对动物致病的LD50毒株的豚鼠显示出保护作用。对这些免疫球蛋白在实验动物上进行了临床前试验,并在志愿者身上进行了临床试验。当在处理埃博拉病毒的实验室发生事故时,该制剂被用作预防剂。俄罗斯国防部微生物研究所病毒学中心研制出了具有高中和及保护特性的马血清类似制剂。其预防效果在感染的狨猴身上也得到了证实。